ARS Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
SPRY
CUSIP
82835W108
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 82835W108 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13D/A
11.1% 10/1/2025
Event 9/29/2025
Rubric Capital Management LP 13G/A
8.1% 5/15/2026
Event 3/31/2026
James E. Flynn 13D/A
7.8% 8/1/2025
Event 7/30/2025
BlackRock, Inc. 13G 5.3% 7/27/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Millennium Management LLC 13G/A
2.5% 7/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 192 88.6 M $382M
2026 Q2 209 90.6 M $726M
2026 Q1 205 94.1 M $757M
2025 Q4 194 90.2 M $1.05B
2025 Q3 192 83.6 M $840M
2025 Q2 193 84.5 M $1.48B
2025 Q1 188 76.3 M $960M
2024 Q4 170 71.3 M $752M
2024 Q3 154 64.1 M $928M
2024 Q2 117 62.6 M $533M
2024 Q1 115 59.9 M $612M
2023 Q4 101 65.4 M $359M
2023 Q3 100 66.5 M $252M
2023 Q2 95 55.1 M $369M
2023 Q1 91 53.4 M $348M
2022 Q4 74 50.2 M $428M
2022 Q3 63 30.4 M $160M
2022 Q2 65 26.1 M $111M
2022 Q1 72 27.0 M $94.7M
2021 Q4 75 30.1 M $200M
2021 Q3 76 28.9 M $288M
2021 Q2 77 28.0 M $865M
2021 Q1 69 27.7 M $1.21B
2020 Q4 63 24.4 M $1.13B